Alpha-hydroxy amides as bradykinin antagonists or inverse agonists

Details for Australian Patent Application No. 2004309357 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Anthony, Neville J.; Bock, Mark G.; Wood, Michael R.; Kuduk, Scott D.

Agent Spruson & Ferguson

Pub. Number AU-B-2004309357

PCT Pub. Number WO2005/063690

Priority 60/624,958 04.11.04 US; 60/531,643 22.12.03 US; 60/539,637 28.01.04 US

Filing date 17 December 2004

Wipo publication date 14 July 2005

Acceptance publication date 7 October 2010

International Classifications

C07C 235/06 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 235/08 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 235/12 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 235/26 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 235/34 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 235/40 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07D 209/12 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 213/56 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/61 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 239/26 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 275/06 (2006.01) Heterocyclic compounds having nitrogen and sulfur as the only ring hetero atoms

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/063690 Priority application(s): WO2005/063690

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

7 October 2010 Application Accepted

  Published as AU-B-2004309357

3 February 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp. 2005

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004309360-Flame retardant compositions and their use

2004309354-Systems, methods, and catalysts for producing a crude product